New Study Gives Researchers a Glimpse into the Mechanism Behind Sustained Remission with Ketamine

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Scientific American posted an article this week. Behind the Buzz: How Ketamine Changes the Depressed Patient’s Brain. In this work, they take a look at new data supporting the effectiveness of Ketamine’s ability to cause remission through synaptogenesis.

Synaptogenesis, the formation of new connections in the brain, is believed to be one of the ways that Ketamine exerts its effects in humans. A new study, produced by multiple centers including Cornell and Stanford, utilized an animal model to demonstrate how this “Prefrontal cortical spine formation sustains the remission of specific depression-related behaviors after ketamine treatment…” Through their research, they were able to conclude that the preservation and enhancement of these synapses may be very useful in promoting sustained remission.

Leave a Comment

Your email address will not be published. Required fields are marked *

More To Explore

Ketamine Clinic

New ICER Report Takes Hard Look at Spravato

The Institute for Clinical and Economic Review (ICER) released a statement on June 19th questioning the efficacy and cost effectiveness of treating resistant depression with esketamine (Spravato). The “report-at-a-glance”, linked *here*, summarizes the *full report*. ICER believes a reduction in price of 25-52% would be needed to improve cost-effectiveness. Spravato’s current list price of $32,400

Sunbelt Health

Sunbelt Joins TriWest Healthcare Alliance!

Everyone has a story that led them to this place; stories that they perceive to be written in ink. When asked about their story, longtime sufferers recite a mantra of pain and hardship ingrained in every aspect of their lives. As providers, we try to break these cycles by utilizing effective treatment regimens. Ketamine, in